Friday, September 9, 2016

Obalon Therapeutics Files For IPO

Carlsbad-based Obalon Therapeutics has filed for an IPO, saying Friday morning that it is looking to raised $75.0M in an IPO on the NASDAQ Global Market. The company has applied to list as OBLN. The company's IPO is being underwritten by UBS Investment Bank, Canaccord Genuity, Stifel, and BTIG. The company is venture backed by Domain Partners, InterWest Partners, Bader SUltan & Bros, and Okapi Venture Capital. Obalonis developing and commercializing a baloon-based medical device to treat obese and overweight people.